Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809453 · ClinicalTrials.gov registry record · Phase 1
Intranasal Cocaine and Temperature Regulation During Exercise
A Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT05809453 is a Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 27 participants.
The verdict
NCT05809453, a Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Assess the effects of intranasal cocaine on temperature regulation and whole-body sweat rate during exercise in warm environmental conditions.
Interventions
- DRUG Lidocaine
- DRUG Cocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-08-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05809453
The ClinicalTrials.gov registry entry for NCT05809453 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT05809453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05809453 about?
NCT05809453 is a clinical study titled "Intranasal Cocaine and Temperature Regulation During Exercise". Assess the effects of intranasal cocaine on temperature regulation and whole-body sweat rate during exercise in warm environmental conditions.
What is the current status of trial NCT05809453?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2023-09-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05809453?
The interventions under investigation include: Lidocaine (DRUG), Cocaine (DRUG).
Who is sponsoring clinical trial NCT05809453?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.